Author

Now showing items 1-1 of 1

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line Stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out Stavudine

Tang MW; Rhee S-Y; Bertagnolio S; Ford N; Holmes S; Sigaloff KC; Hamers RL; de Wit TFR; Fleury HJ; Kanki PJ; Ruxrungtham K; Hawkins CA; Wallis C; Stevens WS; Van Zyl GU; ET AL (UNIV CHICAGO PRESS, 1427 E 60TH ST, CHICAGO, USA, IL, 60637-2954, 2013)